Abstract

Direct oral anticoagulants have become more popular in recent years and have largely replaced vitamin K antagonists in the treatment of certain conditions, such as stroke prevention in atrial fibrillation and venous thromboembolism. Rivaroxaban is one of the direct oral anticoagulants that inhibit factor Xa and a rare cause of peritoneal haemorrhage which is uncommon and life-threatening complication. In this report, we present a 29-year-old female patient using rivaroxaban due to deep vein thrombosis after pregnancy and developing intraperitoneal hemorrhage around terminal ileum and cecum clinically mimicking acute appendicitis.

Highlights

  • For many decades, vitamin K antagonists (VKAs) had been the standard anticoagulation regimen in indications of stroke prevention in atrial fibrillation (SPAF) and treatment of venous thromboembolism (VTE) [1]

  • VKAs have a great number of food–drug and drug–drug interactions

  • Co-prescribed drugs interacting with VKAs are antibiotics, diuretics and nonsteroidal anti-inflammatory drugs (NSAIDs)

Read more

Summary

Introduction

Vitamin K antagonists (VKAs) had been the standard anticoagulation regimen in indications of stroke prevention in atrial fibrillation (SPAF) and treatment of venous thromboembolism (VTE) [1]. Direct oral anticoagulants (DOAC) are increasingly prefered over VKA because of rapid onset and offset of action, having more predictable pharmacodynamics, lower potential of food­ drug or drug­drug interactions and fewer bleeding complications [4]. A 29-year-old woman presented to the emergency department with complaints of right lower quandrant (RLQ) pain and vomiting for 1 day She was receiving rivaroxaban 20 mg once a day because the history of deep vein thrombosis after labor 3 months ago and was healthy until beginning of abdominal pain. Abdominal computed tomography (CT) was planned to confirm diagnosis It revealed appendiceal dilatation (9.1mm), mild pericecal appendicular fat heterogeneity and pericecal fluid accumulation (Figure 1). The patient was stable after discontinuation of rivaroxaban and hemoglobin level was not dropping She was discharged 4 days after surgery

Discussion
Findings
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.